Welcome to the MGH FTD Unit
Document Actions
The staff of the MGH Frontotemporal Disorders (FTD) Unit includes:
Dr. Brad Dickerson, M.D., Director (Behavioral neurologist)
Daisy Sapolsky, M.S., CCC-SLP, Founding Speech and Language Pathologist
Dr. Kimiko Domoto-Reilly, M.D., Behavioral Neurology fellow
Paige Nalipinski, M.S., CCC-SLP, Senior Speech and Language Pathologist
Dr. Janet Sherman, Ph.D., Director of Neuropsychology
Dr. Cathy Leveroni, Ph.D., Neuropsychologist
Dr. Mimi Castelo, Ph.D., Neuropsychologist
Dr. David Caplan, M.D., Ph.D., Behavioral Neurologist and Linguist
Alyson Negreira, B.S., Clinical and Neuropsychological Technician, Support group leader
Mike Brickhouse, B.S., Neuroimaging Technologist
Ayana Cole, B.A., Clinical Coordinator
Dr. Belen Pascual, Ph.D., Research fellow
Dr. Scott McGinnis, M.D., Behavioral Neurologist
Dr. Kristen Lindquist, Ph.D., Research fellow
Former members
Akram Bakkour, B.S., Neuroimaging Technologist
Dr. Lucille Pellerin, M.D., Visiting clinical research fellow
The MGH FTD Unit aims to develop better
knowledge about and diagnosis and treatment of all forms of FTD and
related focal dementia syndromes. The PPA Program aims to better
understand and treat primary progressive aphasia syndromes using existing
technologies (including speech therapy) and by developing new diagnostic
and treatment technologies.
Our research is generously funded by the National Institute on Aging and the Alzheimer's Association.